IP Library Granted Patent US 11,092,604
Granted Patent B2
US 11,092,604 · App. 14/946,550 · Granted Aug 17, 2021

Glucose sensor molecule

Inventors: Nicholas Paul Barwell (Coventry, GB); Tony James (Bath, GB)
Assignees: Baxter International Inc.; Baxter Healthcare SA
G01N33/66A61B5/1495C07F5/025A61B5/1455A61B5/14532G01N2400/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,092,604
App. No.
14/946,550
Granted
Aug 17, 2021
Kind
B2
Abstract

The present invention provides a glucose sensor having a glucose receptor containing a binding site of formula (I): wherein X, n, m and R 1 are defined herein. Also provided is a glucose sensor molecule for use in such a glucose sensor, the glucose sensor molecule containing the binding site of formula (I). The binding site has been found to have particularly good selectivity for glucose.

Claims (22)

1. A glucose sensor comprising a membrane and a glucose receptor having a binding site of formula (Ia):

wherein p is from 1 to 4;

q is from 0 to 3, and p+q is 4;

X is N;

each R 1 is the same or different and represents hydrogen, C 1-4 alkyl or C 3-7 cycloalkyl; and

ring A is a C 3-7 cycloalkyl group or a 5- to 7-membered heterocyclyl group.

2. A process for preparation of the glucose sensor of claim 1 , wherein the process comprises reductive amination of (III) in the presence of (IV), followed by deprotection of the boronic acid group:

wherein p is from 1 to 4;

q is from 0 to 3, and p+q is 4;

X is N;

each R 1 is the same or different and represents hydrogen, C 1-4 alkyl or C 3-7 cycloalkyl; and

ring A is a C 3-7 cycloalkyl group or a 5- to 7-membered heterocyclyl group;

wherein B(PG) is a boronic acid group protected by a protecting group.

3. A method of detecting or quantifying the amount of glucose in an analyte, the method comprising contacting the analyte with a glucose receptor comprising a binding site of formula (Ia):

wherein p is from 1 to 4;

q is from 0 to 3, and p+q is 4;

X is N;

each R 1 is the same or different and represents hydrogen, C 1-4 alkyl or C 3-7 cycloalkyl; and

ring A is a C 3-7 cycloalkyl group or a 5- to 7-membered heterocyclyl group.

4. A method according to claim 3 , wherein the method is a fluorescence sensing method comprising detecting a change in the fluorescence of the sensor when glucose is bound to the glucose receptor.

5. A method according to claim 4 , wherein the change in fluorescence is a change in fluorescence lifetime.

6. A method according to claim 4 , wherein the change in fluorescence is a change in fluorescence intensity.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER INTERNATIONAL INC.
To: VANTIVE US HEALTHCARE LLC
Reel/Frame 074042/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER HEALTHCARE SA
To: VANTIVE HEALTH GMBH
Reel/Frame 074046/0139 →
SECURITY INTEREST Recorded Jan 31, 2025
From: VANTIVE US HEALTHCARE LLC; GAMBRO RENAL PRODUCTS, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 070076/0701 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2019
From: LIGHTSHIP MEDICAL LIMITED
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE SA
Reel/Frame 048822/0461 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2016
From: BARWELL, NICHOLAS PAUL; JAMES, TONY
To: GLYSURE LTD.
Reel/Frame 039781/0585 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2016
From: GLYSURE LTD.
To: LIGHTSHIP MEDICAL LIMITED
Reel/Frame 039781/0598 →